Non-alcoholic fatty liver disease adversely affects the glycemic control afforded by sitagliptin.

Abstract

BACKGROUND/AIMS Recently, high serum DPP-4 activity was found in patients with NAFLD. Therefore, the possibility of NAFLD adversely influencing the therapeutic effect afforded by DPP-4 inhibitors in type 2 diabetic patients was suggested. METHODOLOGY A total of 20 type 2 DM patients with NAFLD and 85 type 2 DM patients without NAFLD were enrolled in the… (More)
DOI: 10.5754/hge11689

Topics

Cite this paper

@article{Iwasaki2012NonalcoholicFL, title={Non-alcoholic fatty liver disease adversely affects the glycemic control afforded by sitagliptin.}, author={Tomoyuki Iwasaki and Wataru Tomeno and Masato Yoneda and Masahiko Inamori and Jun Shirakawa and Kento Imajo and Keigo Kawashima and Yasuo Terauchi and Atsushi Nakajima}, journal={Hepato-gastroenterology}, year={2012}, volume={59 117}, pages={1522-5} }